NCT03085940View on ClinicalTrials.gov

Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 20, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Hydroxychloroquine

Hydroxychloroquine 400mg once daily initially

DRUG

Placebo

Placebo

Trial Locations (1)

10430

Ciptomangunkusumo Hospital, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT03085940 - Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter